PMID- 30940777 OWN - NLM STAT- MEDLINE DCOM- 20200420 LR - 20200420 IS - 1573-4935 (Electronic) IS - 0144-8463 (Print) IS - 0144-8463 (Linking) VI - 39 IP - 4 DP - 2019 Apr 30 TI - Anti-depressant effects of oil from fructus gardeniae via PKA-CREB-BDNF signaling. LID - BSR20190141 [pii] LID - 10.1042/BSR20190141 [doi] AB - The dried ripe fruit of Gardenia jasminoides Ellis was usually applied as an herb medicine in Traditional Chinese Medicine. It was suggested that the Gardenia jasminoides oil extract (oil from Fructus Gardeniae [OFG]) might serve as a potential treatment for depression, whereas its pathogenesis still remained not fully understood. The present research was conducted to evaluate the anti-depressive effect of OFG in mice and explore its potential mechanism. The OFG and ketamine (KET) were intragastrically and intraperitoneally treated, respectively. Thereafter, the animals were subjected to the behavior tests. The expressions of protein kinase A (PKA), brain derived neurotrophic factor (BDNF), cAMP response element-binding protein (CREB) in hippocampus were detected by Western blot. The selective PKA inhibitor H-89 was also applied to confirm the mechanism. As a result, OFG and KET treatment improved the behavior performance. Furthermore, the administrations of OFG effectively enhanced the expressions of PKA, p-CREB, and BDNF. With the application of selective PKA inhibitor H-89, the ameliorated effects caused by OFG were blocked, but not by KET. In conclusion, the presented work indicated that OFG-exerted protective effect on depression through PKA-CREB-BDNF signaling. CI - (c) 2019 The Author(s). FAU - Ruan, Jie AU - Ruan J AD - Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 211198, China. FAU - Liu, Li AU - Liu L AD - Guangdong Medical University, Dongguan 523808, China. FAU - Shan, Xin AU - Shan X AD - Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 211198, China. FAU - Xia, Baomei AU - Xia B AD - Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 211198, China. FAU - Fu, Qiang AU - Fu Q AUID- ORCID: 0000-0002-1416-8336 AD - Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 211198, China qiangfucpu@163.com. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20190426 PL - England TA - Biosci Rep JT - Bioscience reports JID - 8102797 RN - 0 (Bdnf protein, mouse) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Creb1 protein, mouse) RN - 0 (Cyclic AMP Response Element-Binding Protein) RN - 0 (Isoquinolines) RN - 0 (Plant Oils) RN - 0 (Sulfonamides) RN - 690G0D6V8H (Ketamine) RN - EC 2.7.11.11 (Cyclic AMP-Dependent Protein Kinases) RN - M876330O56 (N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide) SB - IM MH - Animals MH - Behavior, Animal/drug effects MH - Brain-Derived Neurotrophic Factor/*genetics MH - Cyclic AMP Response Element-Binding Protein/*genetics MH - Cyclic AMP-Dependent Protein Kinases/*genetics MH - Depression/*drug therapy MH - Disease Models, Animal MH - Fruit/chemistry MH - Gardenia/*chemistry MH - Gene Expression Regulation/drug effects MH - Hippocampus/drug effects MH - Isoquinolines/pharmacology MH - Ketamine/pharmacology MH - Medicine, Chinese Traditional MH - Mice MH - Plant Oils/chemistry/pharmacology MH - Plants, Medicinal/chemistry MH - Sulfonamides/pharmacology PMC - PMC6487269 OTO - NOTNLM OT - Depression OT - Gardenia jasminoides oil extract OT - PKA/CREB/BDNF COIS- The authors declare that there are no competing interests associated with the manuscript. EDAT- 2019/04/04 06:00 MHDA- 2020/04/21 06:00 PMCR- 2019/04/26 CRDT- 2019/04/04 06:00 PHST- 2019/01/16 00:00 [received] PHST- 2019/03/19 00:00 [revised] PHST- 2019/03/29 00:00 [accepted] PHST- 2019/04/04 06:00 [pubmed] PHST- 2020/04/21 06:00 [medline] PHST- 2019/04/04 06:00 [entrez] PHST- 2019/04/26 00:00 [pmc-release] AID - BSR20190141 [pii] AID - 10.1042/BSR20190141 [doi] PST - epublish SO - Biosci Rep. 2019 Apr 26;39(4):BSR20190141. doi: 10.1042/BSR20190141. Print 2019 Apr 30.